XML 29 R20.htm IDEA: XBRL DOCUMENT v3.23.3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables)
9 Months Ended
Sep. 30, 2023
SCHEDULE OF POTENTIALLY DILUTIVE SECURITIES

Potentially dilutive securities outlined in the table below have been excluded from the computation of diluted net loss per share the three and nine months ended September 30, 2023 and 2022 because the effect of their inclusion would have been anti-dilutive.

 

   For the three and nine months ended September 30, 2023   For the three and nine months ended September 30, 2022 
Warrants to purchase shares of common stock   609,893    655,463 
Restricted stock units - vested and unissued   20,847    61,428 
Restricted stock units - unvested   148,251    65,117 
Restricted stock awards - vested and unissued       974 
Investment options to purchase shares of common stock   1,070,000    1,070,000 
Options to purchase shares of common stock   31,852    22,829 
Total potentially dilutive securities   1,880,843    1,875,811 
SCHEDULE OF FAIR VALUE HIERARCHY OF VALUATION INPUTS ON RECURRING BASIS

The following table provides the financial liabilities measured on a recurring basis and reported at fair value on the balance sheet as of September 30, 2023, and December 31, 2022, and indicates the fair value of the valuation inputs the Company utilized to determine such fair value of warrant liabilities, derivative liability, and investment options:

 

   Level  September 30, 2023   December 31, 2022 
Warrant liabilities - January 2021 Warrants  3  $18   $81 
Warrant liabilities - February 2021 Warrants  3   59    79 
Warrant liabilities - February 2022 Warrants  3   300,480    185,055 
Fair value of warrant liability     $300,557   $185,215 

 

 

ENVERIC BIOSCIENCES, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

   Level  September 30, 2023   December 31, 2022 
Derivative liability - May 2022  3  $   $727,000 
Fair value of derivative liability     $   $727,000 

 

   Level  September 30, 2023   December 31, 2022 
H.C. Wainwright & Co., LLC investment options  3  $70,521   $44,904 
RD investment options  3   442,653    302,289 
PIPE investment options  3   737,755    503,815 
Fair value of investment option liability     $1,250,929   $851,008 
Subsequent Measurement [Member]  
SCHEDULE OF FAIR VALUE OF WARRANT LIABILITIES AND DERIVATIVE LIABILITY AND INVESTMENT OPTIONS

The following table presents the changes in fair value of the warrant liabilities, derivative liability, and investment options that are classified as Level 3:

 

   Total Warrant Liabilities 
Fair value as of December 31, 2022  $185,215 
Change in fair value   115,342 
Fair value as of September 30, 2023  $300,557 

 

   Total Derivative Liability 
Fair value as of December 31, 2022  $727,000 
Change in fair value arising from redemption of Akos Series A Preferred Stock - See Note 8   (727,000)
Fair value of derivative liability as of September 30, 2023  $ 

 

   Total Investment Option Liability 
Fair value as of December 31, 2022  $851,008 
Change in fair value   399,921 
Fair value of investment option liability as of September 30, 2023  $1,250,929 
SCHEDULE OF BLACK SCHOLES VALUATION MODELS OF WARRANT LIABILITIES AND INVESTMENT OPTIONS

The key inputs into the Black Scholes valuation model for the Level 3 valuations of the warrant liabilities as of September 30, 2023 are below:

 

   January 2021 Warrants   February 2021 Warrants   February 2022 Warrants   February 2022 Post-Modification Warrants 
Term (years)   2.3    2.4    3.4    4.3 
Stock price  $2.38   $2.38   $2.38   $2.38 
Exercise price  $247.50   $245.00   $27.50   $7.78 
Dividend yield   %   %   %   %
Expected volatility   80.0%   85.0%   96.0%   94.0%
Risk free interest rate   5.00%   4.90%   4.80%   4.70%
Number of warrants   36,429    34,281    338,000    122,000 
Value (per share)  $   $   $0.46   $1.18 

 

The key inputs into the Black Scholes valuation model for the Level 3 valuations of the investment options as of September 30, 2023 are below:

 

   H.C. Wainwright & Co., LLC Options   RD Offering Options   PIPE Offering Options 
Term (years)   3.8    4.3    4.3 
Stock price  $2.38   $2.38   $2.38 
Exercise price  $10.00   $7.78   $7.78 
Dividend yield   %   %   %
Expected volatility   97.0%   94.0%   94.0%
Risk free interest rate   4.70%   4.70%   4.70%
Number of investment options   70,000    375,000    625,000 
Value (per share)  $1.01   $1.18   $1.18 

 

The key inputs into the Weighted Expected Return valuation model for the Level 3 valuations of the derivative liability as of redemption, are below:

 

    May 2022 Derivative Liability 
Principal  $ 
Dividend rate   %
Market rate   %